HomeCompareXBIOW vs STAG

XBIOW vs STAG: Dividend Comparison 2026

XBIOW yields 11.40% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XBIOW wins by $24.1K in total portfolio value
10 years
XBIOW
XBIOW
● Live price
11.40%
Share price
$17.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.5K
Annual income
$2,326.31
Full XBIOW calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.06
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.70
Full STAG calculator →

Portfolio growth — XBIOW vs STAG

📍 XBIOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXBIOWSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XBIOW + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XBIOW pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XBIOW
Annual income on $10K today (after 15% tax)
$969.21/yr
After 10yr DRIP, annual income (after tax)
$1,977.36/yr
STAG
Annual income on $10K today (after 15% tax)
$292.69/yr
After 10yr DRIP, annual income (after tax)
$393.29/yr
At 15% tax rate, XBIOW beats the other by $1,584.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XBIOW + STAG for your $10,000?

XBIOW: 50%STAG: 50%
100% STAG50/50100% XBIOW
Portfolio after 10yr
$30.4K
Annual income
$1,394.51/yr
Blended yield
4.59%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

XBIOW
No analyst data
Altman Z
-29.7
Piotroski
3/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.8% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XBIOW buys
0
STAG buys
0
No recent congressional trades found for XBIOW or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXBIOWSTAG
Forward yield11.40%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$42.5K$18.3K
Annual income after 10y$2,326.31$462.70
Total dividends collected$17.2K$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: XBIOW vs STAG ($10,000, DRIP)

YearXBIOW PortfolioXBIOW Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$11,840$1,140.25$10,665$345.38+$1.2KXBIOW
2$13,931$1,261.76$11,365$358.01+$2.6KXBIOW
3$16,293$1,387.43$12,099$370.76+$4.2KXBIOW
4$18,951$1,516.57$12,870$383.63+$6.1KXBIOW
5$21,926$1,648.49$13,678$396.60+$8.2KXBIOW
6$25,243$1,782.51$14,526$409.67+$10.7KXBIOW
7$28,928$1,917.94$15,413$422.82+$13.5KXBIOW
8$33,007$2,054.14$16,343$436.05+$16.7KXBIOW
9$37,508$2,190.46$17,315$449.35+$20.2KXBIOW
10$42,460$2,326.31$18,332$462.70+$24.1KXBIOW

XBIOW vs STAG: Complete Analysis 2026

XBIOWStock

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Full XBIOW Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this XBIOW vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XBIOW vs SCHDXBIOW vs JEPIXBIOW vs OXBIOW vs KOXBIOW vs MAINXBIOW vs PLDXBIOW vs EQRXBIOW vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.